Authors: MANI S MICHELASSI F WADE J KUGLER J GERSTNER J GEOFFROY F ANSARI R ARRIETA R MURGO A SCHILSKY R VOKES E

Citation: S. Mani et al., PHASE-II TRIAL OF PYRAZOLOACRIDINE (NSC-3661400) IN PATIENTS WITH ADVANCED PANCREATIC AND HEPATOBILIARY CANCER, Annals of oncology, 9, 1998, pp. 673-673

Authors: GERSTNER J

Citation: J. Gerstner, GRADIENT ELUTION - REPLY, Chemistry in Britain, 33(4), 1997, pp. 19-19

Authors: GERSTNER J

Citation: J. Gerstner, CLEANER SEPARATIONS, Chemistry in Britain, 33(2), 1997, pp. 40-42

Authors: WITZIG TE LETENDRE L GERSTNER J SCHROEDER G MAILLIARD JA COLONOTERO G MARSCHKE RF WINDSCHITL HE

Citation: Te. Witzig et al., EVALUATION OF A SOMATOSTATIN ANALOG IN THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP TRIAL, Journal of clinical oncology, 13(8), 1995, pp. 2012-2015

Authors: PIAGGIO G TOMEI L TONIATTI C DEFRANCESCO R GERSTNER J CORTESE R

Citation: G. Piaggio et al., LFB1 HNF1 ACTS AS A REPRESSOR OF ITS OWN TRANSCRIPTION/, Nucleic acids research, 22(20), 1994, pp. 4284-4290

Authors: WITZIG TE GERSTNER J MAILLIARD JA SCHROEDER G

Citation: Te. Witzig et al., EVALUATION OF A SOMATOSTATIN ANALOG (SMS-201-995, SANDOSTATIN(R)) IN THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMAS (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - RESULTS OF A PHASE-II NORTH CENTRAL CANCER-TREATMENT GROUP (NCCTG) TRIAL, Blood, 84(10), 1994, pp. 10000169-10000169